| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |